Published in Res Commun Chem Pathol Pharmacol on July 01, 1975
Catecholamine transport in isolated lung parenchyma of pig. Br J Pharmacol (1982) 0.94
Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma. Br Med J (1973) 2.65
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis (2009) 2.29
Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv (1999) 2.11
BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry (2005) 2.00
Some bronchoconstricting and bronchodilating responses of human isolated bronchi: evidence for the existence of -adrenoceptors. J Pharm Pharmacol (1971) 1.68
Effect of prostaglandins F2 alpha and E2 on airway conductance in healthy subjects and asthmatic patients. Am Rev Respir Dis (1975) 1.66
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
Release of prostaglandins and metabolites from guinea-pig lung: inhibition by catecholamines. Prostaglandins (1973) 1.26
Animal models of depression and anxiety: What do they tell us about human condition? Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.23
Relationships among digital clubbing, disease severity, and serum prostaglandins F2alpha and E concentrations in cystic fibrosis patients. Am Rev Respir Dis (1978) 1.22
A pilot Swedish twin study of affective illness, including hospital- and population-ascertained subsamples. Arch Gen Psychiatry (1993) 1.22
Cortisol and Alzheimer's disease, I: Basal studies. Am J Psychiatry (1986) 1.20
Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia (1995) 1.20
A pilot Swedish twin study of affective illness including hospital- and population-ascertained subsamples: results of model fitting. Behav Genet (1995) 1.18
A twin study of generalized anxiety disorder and major depression. Psychol Med (1995) 1.15
Sinus node dysfunction during long-term lithium treatment. Br Heart J (1993) 1.14
Blockade by polyphloretin phosphate of the prostaglandin F2a action on isolated human bronchi. Nat New Biol (1971) 1.14
Visceral learning in asthma. Psychosom Med (1976) 1.10
Release of prostaglandins and histamine from sensitized and anaphylactic guinea pig lungs--changes in cyclic AMP levels. Biochem Pharmacol (1977) 1.09
Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res (1998) 1.08
Release of prostaglandins from healthy and sensitized guinea-pig lung and trachea by histamine. Prostaglandins (1976) 1.07
Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N Engl J Med (1973) 1.06
Age of onset in affective disorder: its correlation with hereditary and psychosocial factors. J Affect Disord (2000) 1.00
Oral physostigmine treatment of patients with Alzheimer's disease. Am J Psychiatry (1985) 1.00
Decreased plasma free fatty acids and urinary epinephrine in bronchial asthma. N Engl J Med (1969) 0.99
A comparison between microwave irradiation and decapitation: basal levels of dynorphin and enkephalin and the effect of chronic morphine treatment on dynorphin peptides. Neuropeptides (1997) 0.98
Antagonism of prostaglandin F 2 induced bronchoconstriction and blood pressure changes by polyphloretin phosphate in the guinea-pig and cat. J Pharm Pharmacol (1972) 0.98
Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res (2000) 0.97
Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats. Brain Res Dev Brain Res (2001) 0.97
Release of histamine and formation of prostaglandins in human lung tissue and rat mast cells. Int Arch Allergy Appl Immunol (1977) 0.97
Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Mol Psychiatry (2011) 0.97
GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells. Mol Pharmacol (1987) 0.96
Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres. Transl Psychiatry (2013) 0.96
Aspects of prostaglandin function in the lung (first of two parts). N Engl J Med (1977) 0.96
Alpha-adrenergic receptors in the human lung. Psychosom Med (1972) 0.95
Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant (1994) 0.93
Microwave irradiation increases recovery of neuropeptides from brain tissues. Peptides (1991) 0.92
Impaired neuropsychological performance in euthymic patients with recurring mood disorders. J Clin Psychiatry (1997) 0.92
Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. Mol Pharmacol (1988) 0.91
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication? Mol Psychiatry (2007) 0.90
Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav Brain Res (1995) 0.88
Opioid receptor desensitization in NG 108-15 cells. Differential effects of a full and a partial agonist on the opioid-dependent GTPase. Biochem Pharmacol (1987) 0.87
Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats. Neuropharmacology (2002) 0.87
Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport (2000) 0.86
Percutaneous drainage of hepatic abscesses in children. J Pediatr Surg (1986) 0.86
Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. J Neurosci Res (1989) 0.85
Propranolol effects on acute marihuana intoxication in man. Psychopharmacology (Berl) (1977) 0.85
Effect of anaphylaxis and histamine, pyrilamine and burimamide on levels of cyclic AMP and cyclic GMP in guinea-pig lung. Res Commun Chem Pathol Pharmacol (1974) 0.84
Regulation of cytoskeleton machinery, neurogenesis and energy metabolism pathways in a rat gene-environment model of depression revealed by proteomic analysis. Neuroscience (2010) 0.83
Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electroconvulsive stimuli. J Psychiatr Res (2001) 0.83
Changes in dietary fatty acids alter phospholipid fatty acid composition in selected regions of rat brain. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.83
Allele-specific programming of Npy and epigenetic effects of physical activity in a genetic model of depression. Transl Psychiatry (2013) 0.83
Norepinephrine release from the lung by sympathetic nerve stimulation inhibition by vagus and methacholine. Life Sci (1977) 0.82
Aspects of prostaglandin function in the lung (second of two parts). N Engl J Med (1977) 0.82
Airway resistance and emotional state in bronchial asthma. Psychosom Med (1968) 0.82
Release of norepinephrine by sympathetic nerve stimulation from rabbit lungs. Am J Physiol (1978) 0.82
Long term treatment with CV 205-502 in patients with prolactin-secreting pituitary macroadenomas. J Clin Endocrinol Metab (1990) 0.82
Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms. Am J Psychiatry (1986) 0.82
Development of noninvasive and quantitative methodologies for the assessment of chronic ulcers and scars in humans. Wound Repair Regen (2001) 0.82
Positive end-expiratory pressure, lung stretch, and decreased myocardial contractility. Surgery (1978) 0.81
Exacerbated loss of cell survival, neuropeptide Y-immunoreactive (IR) cells, and serotonin-IR fiber lengths in the dorsal hippocampus of the aged flinders sensitive line "depressed" rat: Implications for the pathophysiology of depression? J Neurosci Res (2006) 0.81
Ultrasound finding of peripelvic urine extravasation in ureteropelvic junction obstruction. Pediatr Radiol (1989) 0.81
Hydroxyl radical production in the cortex and striatum in a rat model of focal cerebral ischemia. Can J Neurol Sci (2000) 0.81
Marihuana effects on learning, attention and time estimation. Psychopharmacologia (1974) 0.81
Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression. Neurosci Lett (1999) 0.81
Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group. Seizure (2000) 0.81
Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. Behav Brain Res (2000) 0.81
Effect of epinephrine on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in control and antigen-sensitized guinea pig lungs. Pharmacology (1976) 0.80
Autosomal recessive LMNA mutation causing restrictive dermopathy. Clin Genet (2010) 0.80
Impact of early life stress on alcohol consumption and on the short- and long-term responses to alcohol in adolescent female rats. Behav Brain Res (2011) 0.80
Emotional and adrenal reactions to stress in bronchial asthma. Psychosom Med (1971) 0.80
Modification of guinea pig lung anaphylaxis by central nervous system (CNS) perturbations. J Allergy Clin Immunol (1989) 0.79
Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies. J Am Geriatr Soc (1985) 0.79
Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology (2000) 0.79
Neuroendocrine and neurochemical measurements in depression. Am J Psychiatry (1981) 0.79
Impact of an intense stress on ethanol consumption in female rats characterized by their pre-stress preference: modulation by prenatal stress. Brain Res (2006) 0.79
Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies. J Am Geriatr Soc (1985) 0.79
Tryptophan depletion in lithium-stabilized patients with affective disorder. Int J Neuropsychopharmacol (2001) 0.78
Substance P and neurokinin levels are decreased in the cortex and hypothalamus of alcohol-preferring (P) rats. J Stud Alcohol (2001) 0.78
Serum amylase in patients treated with lithium. Psychopharmacology (Berl) (1990) 0.78
Prostaglandin release by slow reacting substance from guinea pig and human lung tissue. Prostaglandins (1977) 0.78
Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neurosci Lett (1995) 0.78
Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Brain Res Mol Brain Res (1995) 0.78
In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors: electrospray-MS analysis of intra-striatal microdialysates. J Mass Spectrom (1996) 0.78
Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum. J Neurosci Res (2000) 0.77
Evaluation of sodium 4-hydroxybenzoate as an hydroxyl radical trap using gas chromatography-mass spectrometry and high-performance liquid chromatography with electrochemical detection. Anal Biochem (1996) 0.77
Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA (1991) 0.77
Brain neuropeptides: tachykinins, neuropeptide Y, neurotensin and vasoactive intestinal polypeptide in the rat brain: modifications by ECT and indomethacin. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.77
Changed concentrations of tachykinins and neuropeptide Y in brain of a rat model of depression: lithium treatment normalizes tachykinins. Neuropsychopharmacology (2001) 0.77
Identification of the bioactive peptide PEC-60 in brain. Cell Mol Life Sci (2003) 0.77
Dopamine receptor antagonists prevent the d-amphetamine-induced increase in calcitonin gene-related peptide levels in ventral striatum. J Neurosci Res (2001) 0.77
Age and the dexamethasone suppression test in depression. Am J Psychiatry (1984) 0.77
Bromocriptine in the treatment of alcohol dependence. Alcohol Clin Exp Res (1991) 0.77
A pilot study of rat brain regional distribution of calcitonin, katacalcin and calcitonin gene-related peptide before and after antipsychotic treatment. Neuropeptides (2002) 0.77
Studies on actions of prostaglandins in the lung. Acta Physiol Scand Suppl (1976) 0.77
Acrocephalospondylosyndactyly--a possible new syndrome: analysis of the vertebral and intervertebral components. Pediatr Pathol (1990) 0.77
Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. Biol Psychiatry (1999) 0.76
Repeated electroconvulsive stimuli: changes in neuropeptide Y, neurotensin and tachykinin concentrations in time. Prog Neuropsychopharmacol Biol Psychiatry (1994) 0.76
Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders. Acta Psychiatr Scand (1998) 0.76